Skip to main content

Determine Sensitivity of Skin to Cetaphil Daily Advance Ultra Hydrating Lotion

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Galderma
GaldermaTX - Dallas
1 program
Cetaphil Daily Advance Ultra Hydrating LotionN/A1 trial
Active Trials
NCT01885130Completed100

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GaldermaCetaphil Daily Advance Ultra Hydrating Lotion

Clinical Trials (1)

Total enrollment: 100 patients across 1 trials

NCT01885130GaldermaCetaphil Daily Advance Ultra Hydrating Lotion

Patch Test Skin Irritation/Sensitization of Cetaphil Daily Advance Ultra Hydration Lotion

Start: Dec 2012100 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.